Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DT204 |
Trade Name | |
Synonyms | |
Drug Descriptions |
DT204 is a SCF/SKP2 inhibitor that targets the ubiquitin/proteasome system, specifically inhibiting SKP1, CUL1, and COMMD1, which may result in restored sensitivity to proteasome inhibitors or overcome proteasome inhibitor resistance (PMID: 27677741). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bortezomib + DT204 | Bortezomib DT204 | 0 | 0 |
Carfilzomib + DT204 | Carfilzomib DT204 | 0 | 0 |
DT204 | DT204 | 0 | 0 |
DT204 + Ixazomib | DT204 Ixazomib | 0 | 0 |